| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/19/2004 | US20040033510 Using uniform extension and visualization of DNA and/or RNA to detect trisomic chromosomes |
| 02/19/2004 | US20040033505 Novel peptide, an n-acetylgalactosamine transferase-28 and the polynucleotide encoding polypeptide |
| 02/19/2004 | US20040033504 Novel compounds |
| 02/19/2004 | US20040033503 Method for attaching oligonucleotide to solid support and the oligonucleotide array prepared by the method thereof |
| 02/19/2004 | US20040033499 Preparing double stranded DNA from messenger RNA using modified/genetically engineered primase; biosynthesis of complimentary nucleotide sequences |
| 02/19/2004 | US20040033494 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/19/2004 | US20040033491 Proteins and nucleic acids encoding same |
| 02/19/2004 | US20040033490 Epigenetic sequences for esophageal adenocarcinoma |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033481 Preparing and designing antigrowth modulators which inhibit methionyl-tRNA synthetase activities in microscopic pathogens |
| 02/19/2004 | US20040033479 Preparing transformation capable or transgenic aggregates for use as bioreactors in expressing heterologous proteins |
| 02/19/2004 | US20040033239 Adenovirus formulations |
| 02/19/2004 | US20040033238 Selectable genetic marker for use in pasteurellaceae species |
| 02/19/2004 | US20040033237 Immunogenicity using a combination of dna and vaccinia virus vector vaccines |
| 02/19/2004 | US20040033236 Recombinant constructs of borrelia burgdorferi |
| 02/19/2004 | US20040033235 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 02/19/2004 | US20040033234 Immunogenic polypetides encoded by mage minigenes and uses thereof |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040033227 Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof |
| 02/19/2004 | US20040033215 Transferring a cell proliferation factor gene into a mammalian liver cell, for an in vitro immortalized cell, proliferating the immortalized cell, and removing the cell proliferation factor gene |
| 02/19/2004 | DE10236001A1 Producing transgenic plants transformed in the plastome, by introducing two DNA segments each containing a region homologous with plastome nucleic acid |
| 02/19/2004 | DE10234905A1 Transferring molecules of active agents in cells comprises use of pulsed acoustic waves to generate shear forces on the sample volume containing scattered bodies in vivo or in vitro |
| 02/19/2004 | CA2818693A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2759572A1 Isolation and identification of t cells |
| 02/19/2004 | CA2534874A1 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | CA2497662A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | CA2496002A1 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | CA2495660A1 Mutant e. coli appa phytase enzymes |
| 02/19/2004 | CA2495563A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | CA2495545A1 Plastid transformation using modular vectors |
| 02/19/2004 | CA2495456A1 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 02/19/2004 | CA2495289A1 Interferon-.alpha. induced gene |
| 02/19/2004 | CA2495145A1 Staphylococcal nuclease fusion proteins for the production of recombinant peptides |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2495112A1 Mechanisms of myoblast transfer in treating heart failure |
| 02/19/2004 | CA2495100A1 Tissue specific expression of exogenous proteins in transgenic chickens |
| 02/19/2004 | CA2494988A1 Heterologous expression system comprising a b. subtilis promoter |
| 02/19/2004 | CA2494930A1 Modified forms of interfering rna molecules |
| 02/19/2004 | CA2494908A1 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494252A1 Psmcs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | CA2494236A1 Csnk1gs as modifiers of the p21 pathway and methods of use |
| 02/19/2004 | CA2494066A1 Eukaryotic genes involved in adult lifespan regulation |
| 02/19/2004 | CA2493716A1 Uncoupling of dna propagation and expression of protein for phage display |
| 02/19/2004 | CA2493297A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | CA2489301A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/18/2004 | EP1389638A1 Improved fluorescent resonance energy transfer probes |
| 02/18/2004 | EP1389637A1 Novel forms of interfering RNA molecules |
| 02/18/2004 | EP1389306A2 Method for detecting progredient chronic dementia, and corresponding peptides and detection reagents |
| 02/18/2004 | EP1389241A2 Polynucleotide sequencing method |
| 02/18/2004 | EP1389240A2 Mdr1 variants and methods for their use |
| 02/18/2004 | EP1389239A2 Methods and compositions for making emamectin |
| 02/18/2004 | EP1389238A2 Regulation of human prostaglandin-f synthase 1-like protein |
| 02/18/2004 | EP1389237A2 Novel fibroblast growth factors |
| 02/18/2004 | EP1389236A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP1389233A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/18/2004 | EP1389228A2 0etergent compositions comprising bacillus subtilis pectate lyases |
| 02/18/2004 | EP1389206A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 02/18/2004 | EP1389182A1 Complexes for transferring substances of interest into a cell |
| 02/18/2004 | EP1389130A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 02/18/2004 | EP1389128A2 Method for inhibiting atherosclerotic plaque formation |
| 02/18/2004 | EP1389060A1 Imaging of a region in a scattering medium |
| 02/18/2004 | EP1389043A1 Foot and mouth disease virus vaccine |
| 02/18/2004 | EP1194479B1 Process for making fluorinated polymer adsorbent particles |
| 02/18/2004 | EP1178822B1 Whole cell cancer vaccine comprising co-cultured malignant and non-malignant cells |
| 02/18/2004 | EP1137804B1 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro |
| 02/18/2004 | EP1137801B1 Diagnostic method based on the function of a protein produced in a cell-free environement from a nucleic acid sample |
| 02/18/2004 | EP1109624B1 Capillary printing systems |
| 02/18/2004 | EP1028744B1 Neuronal uses of bmp-11 |
| 02/18/2004 | EP0904396B1 Production of vanillin |
| 02/18/2004 | EP0817851B1 Dna encoding human papilloma virus type 18 |
| 02/18/2004 | EP0791064B1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines |
| 02/18/2004 | EP0751995B1 Riboflavin synthesis in fungi |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | EP0663011B1 Synthesis of quinic acid from glucose |
| 02/18/2004 | CN1476485A Reagent box used for detecting non pathogenic or pathogenic A type influenze virus H5 subtype virus |
| 02/18/2004 | CN1476484A Process for producing nucleoside compound |
| 02/18/2004 | CN1476483A Modified vaccinia ankara virus variant |
| 02/18/2004 | CN1476482A Protein translocation into plant cells |
| 02/18/2004 | CN1476481A Isolated luciferases and use thereof |
| 02/18/2004 | CN1476480A Isolated peptides which bind to HLA-C molecules and uses thereof |
| 02/18/2004 | CN1476479A Human protooncogene and protein encoded therein |
| 02/18/2004 | CN1476478A Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/18/2004 | CN1476477A Promoter expressing foreign gene in root and shoot apex |
| 02/18/2004 | CN1476476A Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/18/2004 | CN1476295A Treatment of transgenic corn seeds with pesticide |
| 02/18/2004 | CN1475577A Recombination human bone shaping protein-7 mature peptide |
| 02/18/2004 | CN1475574A Method of preceeding gene conversion against orchid using micropellet bombardment |
| 02/18/2004 | CN1475573A Gland related virus carrier using RNA interfernce phenomenan induction function gene down regulation |
| 02/18/2004 | CN1475572A High expressed high temperature resistant phytase gene in methanol yeast |
| 02/18/2004 | CN1475571A Expression of recombination SARS virus gene in pleiomorphic Hansen yeast and its use |
| 02/18/2004 | CN1475570A Cutin forming cell growth factor-2 |
| 02/18/2004 | CN1475568A New type human death resist protein, its coded sequence and use |
| 02/18/2004 | CN1475565A Yeast expression high specic activity phytase gene obtained using chemical synthesis and molecular evolution |
| 02/18/2004 | CN1475561A Process for producing L-lysine by fermenting |
| 02/18/2004 | CN1475559A Breeding method of acid resistant mutagenic ore immersion bacterial culture |
| 02/18/2004 | CN1475503A New type human bone marrow substrate cell source growth inhibiting factor, its coded sequence and use |
| 02/18/2004 | CN1475502A New withered induced protein, its coded sequence and use |